- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
OSI buys Osteometer MediTech
OSI Systems of Hawthorne, CA, reported last month that it has purchased Danish bone densitometry manufacturer Osteometer MediTech for $7.7 million. Osteometer MediTech offers DTX-200, a forearm dual-energy x-ray (DEXA) densitometer that has been cleared
OSI Systems of Hawthorne, CA, reported last month that it has purchased Danish bone densitometry manufacturer Osteometer MediTech for $7.7 million. Osteometer MediTech offers DTX-200, a forearm dual-energy x-ray (DEXA) densitometer that has been cleared by the Food and Drug Administration. The company also markets an ultrasound bone densitometer, DTU-1, in Europe. Osteometer MediTech applied for premarket approval (PMA) for the device in spring 1998. OSI hopes the deal will give it access to the medical subsystem market, according to executives at the optoelectronic devices company.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
